Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 69 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
681 15.0 months Newly diagnosed GBM 5 Chemotherapy
Radiation
University of Marburg Germany 12/2001
Treatment Details: Patients: This study involved 60 patients with glioblastoma multiforme. The average age of the patients was 57. Treatment: Treatment consisted of simultaneous chemotherapy and radiothera
 
682 15.0 months Advanced colorectal cancer 5 Chemotherapy
Various Greece 1/2003
Treatment Details: Patients: This Phase II study involved 55 patients with advanced colorectal carcinoma. Treatment: Treatment consisted of three chemotherapy drugs irinotecan (camptosar, CPT-11), leucovo
 
683 15.0 months Malignant Pleural Mesothelioma 3 Immunotherapy
Ospedale S. Spirito Italy 2/2001
Treatment Details: Patients: This Phase II study involved 31 patients with malignant pleural mesothelioma. Treatment: The treatment consisted of the injection of human recombinant Interleukin-2 (Proleukin).
 
684 15.0 months Advanced renal cell carcinoma 4 Biologic therapy
University Medical Center Netherlands 3/2004
Treatment Details: Patients: This Phase II trial involved 36 patients with advanced renal cell carcinoma, 24 men and 12 women. Twenty-two patients had undergone prior therapies. All patients had metastasis,
 
685 15.0 months Stage III NSCLC 5 Chemotherapy
Radiation
Mayo Clinic and Mayo Foundation United States 10/2002
Treatment Details: Patients: This Phase III study involved 234 patients with stage III non-small-cell lung cancer. Patients were divided into two groups: Group A (117 patients) and Group B (117 patients).
 
686 15.0 months metastatic melanoma 2 Biologic therapy
Pascale National Cancer Institute Italy 10/2005
Treatment Details: Patients: This Phase I/II study involved 24 patients with metastatic melanoma. Treatment: The treatment consisted of a biological therapy - pegylated arginine deiminase used to lower pl
 
687 15.0 months GBM 5 Chemotherapy
Radiation
Philipps-Universitaet Marburg Germany 4/2005
Treatment Details: Patients: This trial involved 60 patients with newly diagnosed glioblastoma multiforme (GBM). There were 41 men and 19 women, and the mean age was 56 years. All patients had surgery prio
 
688 15.0 months Stage IV melanoma 3 Biologic therapy
The Angeles Clinic and Research Institute United States 7/2011
Treatment Details: Patients: This phase II study involved stage IV melanoma patients who were divided into three separate treatment groups. Group A consisted of 32 patients with a median age of 64 years; 56%
 
689 15.0 months GBM 5 Biologic therapy
Radiation
University Clinic Heidelberg Germany 8/2013
Treatment Details: Patients: This phase 2 study involved 57 patients with newly diagnosed glioblastoma without the mutation called MGMT promoter hypermethylation. The median patient age was 57.6 years and 36
 
690 14.9 months Newly diagnosed GBM 5 Chemotherapy
Radiation
MD Anderson Cancer Center United States 11/2013
Treatment Details: Patients: This phase 3 study involved newly diagnosed glioblastoma patients who were divided into two separate treatment groups. Group A had 411 patients of whom 27% were younger than 50 y
 
Page 69 of 187  | Previous Page  | Next Page